|
|
|
|
|
|
|
>
FreeCE
>
Catalog of Homestudy CE
>
Program Details
|
|
A Review of Pathophysiology and Medicinal Treatment Options of Rheumatoid Arthritis
Continuing Education Credits for Healthcare Professionals
|
Credits
2 Contact Hours
Event Type
HomeStudy
Release Date
Thursday, April 28, 2011
Expiration Date
Tuesday, January 28, 2014
Target Audience
Nurse, Pharmacist, Pharmacy Technician
Program Cost
$4.00
|
.jpg)
|
|
Program Overview
Rheumatoid arthritis (RA) is considered the most common chronic inflammatory autoimmune disease, occurring in 1 to 2% of the worldwide population1-4 However, certain ethnic groups such as Native American Indians (Pima and Chippewa) report a higher incidence, reaching approximately 5%. 1,2,5 The hallmark of rheumatoid arthritis consists of synovial joint inflammation, leading to bone and cartilage destruction. Extra-articular manifestations, including rheumatoid nodules, vasculitis, lymphadenopathy, cardiopulmonary disease and eye inflammation, may also occur.1,3 While the exact etiology is unknown, genetic predisposition in combination with environmental triggers are theorized to increase the risk for rheumatoid arthritis. Incidence increases throughout life, affecting women two to three times more often than men. Early aggressive treatment to manage symptoms and slow disease progression include disease-modifying antirheumatic drugs (DMARDs), adjunctive non-steroidal anti-inflammatory agents and corticosteroids, physical therapy, exercise and rest.1-4 This article focuses on the pathophysiology of rheumatoid arthritis, current medicinal treatment options, and side effects.
Nurse Educational Objectives
-
Understand and describe the pathophysiology for rheumatoid arthritis
-
Understand and list parts of the updated ACR/EULAR classification criteria for RA
-
Describe poor prognostic factors of severe disease and how early intensive treatment strategies studied in the TICORA, CAMERA, and BeSt trials may benefit RA patients
-
Review and list the current treatment options and goals for rheumatoid arthitis, including their contraindications and side effects
Pharmacist Educational Objectives
-
Understand and describe the pathophysiology for rheumatoid arthritis
-
Understand and list parts of the updated ACR/EULAR classification criteria for RA
-
Describe poor prognostic factors of severe disease and how early intensive treatment strategies studied in the TICORA, CAMERA, and BeSt trials may benefit RA patients
-
Review and list the current treatment options and goals for rheumatoid arthitis, including their contraindications and side effects
Pharmacy Technician Educational Objectives
-
In general terms, describe the signs and symptoms of rheumatoid arthritis
-
Identify medications used in the treatment for RA
Activity Type
Knowledge
Accreditation
|
Nurse
|
N-662
|
|
Pharmacist
|
0798-0000-11-026-H01-P
|
|
Pharmacy Technician
|
0798-0000-11-026-H01-T
|
|
|
|
|
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing education. In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on this website.
|
|
Pharmaceutical Education Consultants, Inc. has been approved as a provider of continuing education for nurses by the Maryland Nurses Association which is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation.
|
Faculty
Financial Support By
Pharmaceutical Education Consultants, Inc
Program Documents
|
|
|
|
|
|
|
|
|
|
|
|
Providing quality continuing education online for pharmacists, pharmacy technicians, nurses and other medical professionals since 1990
Pharmcon, Inc. Copyright 2000 * 404 Main Street Conway, SC 29526 * 843-488-5550
|
|